10-Q Filing

SOLENO THERAPEUTICS INC CIK: 1484565 Q1 2024

Filing Information

Form Type	10-Q
Accession Number	`0000950170-24-057109`
Period End Date	20240331
Filing Date	20240509
Fiscal Year	2024
Fiscal Period	Q1
XBRL Instance	slno-20240331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 140 Income Statement 60 Cash Flow Statement 104 Stockholders Equity 36

Balance Sheet 140 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	31.68M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	31.68M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	33.34M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	33.34M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	31.68M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	31.68M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$169.68M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$169.68M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$42.85M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$42.85M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	33.34M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	33.34M	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$106.78M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$106.78M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.60M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.60M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.68M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.68M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$151.22M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$151.22M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$171.36M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$171.36M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$27.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$27.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$407.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$407.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$338.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$338.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$8.75M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$8.75M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$8.26M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$8.26M	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$8.82M	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$8.82M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$165.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$165.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$165.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$165.00K	USD	Point-in-time
Total assets	`Assets`	$168.84M	USD	Point-in-time
Total assets	`Assets`	$168.84M	USD	Point-in-time
Total assets	`Assets`	$180.69M	USD	Point-in-time
Total assets	`Assets`	$180.69M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.02M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.02M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.15M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.15M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$1.23M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$1.23M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$3.13M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$3.13M	USD	Point-in-time
Accrued clinical trial site costs	`AccruedClinicalTrialCostsCurrent`	$2.40M	USD	Point-in-time
Accrued clinical trial site costs	`AccruedClinicalTrialCostsCurrent`	$2.40M	USD	Point-in-time
Accrued clinical trial site costs	`AccruedClinicalTrialCostsCurrent`	$3.39M	USD	Point-in-time
Accrued clinical trial site costs	`AccruedClinicalTrialCostsCurrent`	$3.39M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$273.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$273.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$310.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$310.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.55M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.55M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.51M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.51M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$13.46M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$13.46M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$11.51M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$11.51M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$11.55M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$11.55M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$11.95M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$11.95M	USD	Point-in-time
Long-term lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$130.00K	USD	Point-in-time
Long-term lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$130.00K	USD	Point-in-time
Long-term lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$37.00K	USD	Point-in-time
Long-term lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$37.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$23.18M	USD	Point-in-time
Total liabilities	`Liabilities`	$23.18M	USD	Point-in-time
Total liabilities	`Liabilities`	$25.45M	USD	Point-in-time
Total liabilities	`Liabilities`	$25.45M	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 33,337,079 and 31,678,159 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$32.00K	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 33,337,079 and 31,678,159 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$32.00K	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 33,337,079 and 31,678,159 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$33.00K	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 33,337,079 and 31,678,159 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$33.00K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$433.88M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$433.88M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$441.27M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$441.27M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-106.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-106.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	-	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	-	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-297.81M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-297.81M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-276.41M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-276.41M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$10.35M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$10.35M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$157.51M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$157.51M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$2.64M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$2.64M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$143.39M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$143.39M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$168.84M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$168.84M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$180.69M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$180.69M	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$5.32M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$5.32M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$14.60M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$14.60M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.85M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.85M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$8.47M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$8.47M	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$299.00K	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$299.00K	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$401.00K	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$401.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$8.47M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$8.47M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$23.48M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$23.48M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-8.47M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-8.47M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-23.48M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-23.48M	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$2.08M	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$2.08M	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$113.00K	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$113.00K	USD	1 Quarter
Total other income, net	`NonoperatingIncomeExpense`	$2.08M	USD	1 Quarter
Total other income, net	`NonoperatingIncomeExpense`	$2.08M	USD	1 Quarter
Total other income, net	`NonoperatingIncomeExpense`	$113.00K	USD	1 Quarter
Total other income, net	`NonoperatingIncomeExpense`	$113.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.40M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.40M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.36M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.36M	USD	1 Quarter
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	1 Quarter
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	1 Quarter
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-105.00K	USD	1 Quarter
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-105.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-8.34M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-8.34M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-21.50M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-21.50M	USD	1 Quarter
Net loss per common share basic	`EarningsPerShareBasic`	$-0.88	USD	1 Quarter
Net loss per common share basic	`EarningsPerShareBasic`	$-0.88	USD	1 Quarter
Net loss per common share basic	`EarningsPerShareBasic`	$-0.59	USD	1 Quarter
Net loss per common share basic	`EarningsPerShareBasic`	$-0.59	USD	1 Quarter
Net loss per common share diluted	`EarningsPerShareDiluted`	$-0.88	USD	1 Quarter
Net loss per common share diluted	`EarningsPerShareDiluted`	$-0.88	USD	1 Quarter
Net loss per common share diluted	`EarningsPerShareDiluted`	$-0.59	USD	1 Quarter
Net loss per common share diluted	`EarningsPerShareDiluted`	$-0.59	USD	1 Quarter
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	9.45M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	9.45M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	36.21M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	36.21M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	36.21M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	36.21M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	9.45M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	9.45M	shares	1 Quarter

Cash Flow Statement 104 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-8.36M	USD	1 Quarter
Net loss	`ProfitLoss`	$-8.36M	USD	1 Quarter
Net loss	`ProfitLoss`	$-21.40M	USD	1 Quarter
Net loss	`ProfitLoss`	$-21.40M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$490.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$490.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$490.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$490.00K	USD	1 Quarter
Accretion of premium/discount on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	-	USD	1 Quarter
Accretion of premium/discount on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	-	USD	1 Quarter
Accretion of premium/discount on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$473.00K	USD	1 Quarter
Accretion of premium/discount on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$473.00K	USD	1 Quarter
Non-cash lease expense	`NoncashLeaseExpense`	$78.00K	USD	1 Quarter
Non-cash lease expense	`NoncashLeaseExpense`	$78.00K	USD	1 Quarter
Non-cash lease expense	`NoncashLeaseExpense`	$69.00K	USD	1 Quarter
Non-cash lease expense	`NoncashLeaseExpense`	$69.00K	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$6.45M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$6.45M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$631.00K	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$631.00K	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$299.00K	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$299.00K	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$401.00K	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$401.00K	USD	1 Quarter
Other non-cash reconciling items	`OtherOperatingActivitiesCashFlowStatement`	$-1.00K	USD	1 Quarter
Other non-cash reconciling items	`OtherOperatingActivitiesCashFlowStatement`	$-1.00K	USD	1 Quarter
Other non-cash reconciling items	`OtherOperatingActivitiesCashFlowStatement`	$16.00K	USD	1 Quarter
Other non-cash reconciling items	`OtherOperatingActivitiesCashFlowStatement`	$16.00K	USD	1 Quarter
Prepaid expenses, other current assets and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-81.00K	USD	1 Quarter
Prepaid expenses, other current assets and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-81.00K	USD	1 Quarter
Prepaid expenses, other current assets and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$334.00K	USD	1 Quarter
Prepaid expenses, other current assets and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$334.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.87M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.87M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.00M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.00M	USD	1 Quarter
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-954.00K	USD	1 Quarter
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-954.00K	USD	1 Quarter
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-1.91M	USD	1 Quarter
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-1.91M	USD	1 Quarter
Accrued clinical trial site costs	`IncreaseDecreaseInAccruedClinicalTrialSiteCosts`	$309.00K	USD	1 Quarter
Accrued clinical trial site costs	`IncreaseDecreaseInAccruedClinicalTrialSiteCosts`	$309.00K	USD	1 Quarter
Accrued clinical trial site costs	`IncreaseDecreaseInAccruedClinicalTrialSiteCosts`	$-998.00K	USD	1 Quarter
Accrued clinical trial site costs	`IncreaseDecreaseInAccruedClinicalTrialSiteCosts`	$-998.00K	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-116.00K	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-116.00K	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-56.00K	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-56.00K	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-44.00K	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-44.00K	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$208.00K	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$208.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-12.53M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-12.53M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.73M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.73M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.00K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.00K	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	-	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	-	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$115.23M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$115.23M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-115.24M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-115.24M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Proceeds from exercise of common stock warrants	`ProceedsFromWarrantExercises`	-	USD	1 Quarter
Proceeds from exercise of common stock warrants	`ProceedsFromWarrantExercises`	-	USD	1 Quarter
Proceeds from exercise of common stock warrants	`ProceedsFromWarrantExercises`	$923.00K	USD	1 Quarter
Proceeds from exercise of common stock warrants	`ProceedsFromWarrantExercises`	$923.00K	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	-	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	-	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$15.00K	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$15.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$938.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$938.00K	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-126.83M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-126.83M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-6.73M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-6.73M	USD	1 Quarter
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$14.60M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$14.60M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$169.68M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$169.68M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$42.85M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$42.85M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.87M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.87M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$14.60M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$14.60M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$169.68M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$169.68M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$42.85M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$42.85M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.87M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.87M	USD	Point-in-time
Purchases of property and equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$8.00K	USD	1 Quarter
Purchases of property and equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$8.00K	USD	1 Quarter
Purchases of property and equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	-	USD	1 Quarter
Purchases of property and equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	-	USD	1 Quarter

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Balances at beginning	`StockholdersEquity`	$10.35M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$10.35M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$157.51M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$157.51M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$2.64M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$2.64M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$143.39M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$143.39M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$495.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$495.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.45M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.45M	USD	1 Quarter
Issuance of restricted stock units under equity incentive plans	`IssuanceOfRestrictedStockUnitsValueAndOptionExercisesUnderEquityIncentivePlan`	$136.00K	USD	1 Quarter
Issuance of restricted stock units under equity incentive plans	`IssuanceOfRestrictedStockUnitsValueAndOptionExercisesUnderEquityIncentivePlan`	$136.00K	USD	1 Quarter
Exercise of common stock warrants and pre-funded common stock warrants	`StockIssuedDuringPeriodValueExerciseOfCommonStockWarrantsAndPreFundedCommonStockWarrants`	$923.00K	USD	1 Quarter
Exercise of common stock warrants and pre-funded common stock warrants	`StockIssuedDuringPeriodValueExerciseOfCommonStockWarrantsAndPreFundedCommonStockWarrants`	$923.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$-15.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$-15.00K	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-105.00K	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-105.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.40M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.40M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.36M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.36M	USD	1 Quarter
Balances at ending	`StockholdersEquity`	$10.35M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$10.35M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$157.51M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$157.51M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$2.64M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$2.64M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$143.39M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$143.39M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.